Table 1.
Case number/case | Age/gender | Involved organ(s) | Treatment and follow up | |||||||
---|---|---|---|---|---|---|---|---|---|---|
1. Santucci et al. [1] | 54/M | Skin, CNS | Chemotherapy, died 17 months after diagnosis | |||||||
2. Wu et al. [5] | 41/M | Skin | Chemotherapy, alive and event free at 12 months | |||||||
3. Wu et al. [5] | 47/F | CNS, bone marrow, kidneys, ovaries, cervix | Treatment unclear, died half a month after diagnosis | |||||||
4. Kuo et al.[6] | 71/F | Skin | Alive 5 months after diagnosis without treatment | |||||||
5. Song et al. [7] | 40/F | Skin | Chemotherapy, alive and event free at 7 months | |||||||
6. Nakamichi et al.[8] | 23/F | Skin | Chemotherapy and stem cell transplantation, died of acute GVHD 9 months after diagnosis | |||||||
7. Cerroni et al. [9] | 63/M | Skin | Chemotherapy, died 6 months after diagnosis | |||||||
8. Liao et al. [10] | 42/F | Skin | Chemotherapy and radiotherapy, alive with disease 14 months after diagnosis | |||||||
9. Gebauer et al.[11] | 72/M | Skin, bone marrow, CNS | Chemotherapy, died 7 months after diagnosis | |||||||
10. Liu et al. [12] | 37/F | Skin, CNS | Chemotherapy, died 13 months after diagnosis | |||||||
11.our case | 29/M | Skin, liver | Chemotherapy, died 3 months after diagnosis | |||||||
Case number/case | Immunophenotypes | PCR-TCR | ||||||||
CD3 | CD4 | CD5 | CD8 | CD20 | CD30 | CD56 | Cytotoxic markers | EBER | ||
1. Santucci et al. [1] | + | - | NA | - | - | + | + | + | + | ND |
2. Wu et al. [5] | + | - | - | - | - | - | + | + | + | P |
3. Wu et al. [5] | + | - | - | - | - | NA | + | + | - | P |
4. Kuo et al. [6] | + | - | - | - | - | - | + | + | + | P |
5. Song et al. [7] | + | - | NA | - | - | NA | + | + | + | P |
6. Nakamichi et al.[8] | + | NA | NA | NA | - | NA | + | + | + | ND |
7. Cerroni et al. [9] | + | - | NA | - | - | NA | + | + | + | P |
8. Liao et al.[10] | + | - | - | - | - | - | + | + | + | ND |
9. Gebauer et al.[11] | + | - | NA | - | - | - | + | + | + | P |
10. Liu et al. [12] | + | - | - | - | - | - | + | + | + | ND |
11.our case | + | - | - | - | - | + | + | + | + | P |
M, male; F, female
GVHD, graft-versus-host disease
NA, not available
cytotoxic markers, TIA-1 and/or granzyme B and/or perforin
PCR-TCR, polymerase chain reaction analysis of the T-cell receptor g gene
P, polyclonal smear